<it>ApoE</it> polymorphisms in narcolepsy
<p>Summary</p> <p>Background</p> <p>Narcolepsy is a common neuropsychiatric disorder characterized by increased daytime sleepiness, cataplexy and hypnagogic hallucinations. Deficiency of the hypocretin neurotransmitter system was shown to be involved in the pathogenesis...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
BMC,
2001-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Summary</p> <p>Background</p> <p>Narcolepsy is a common neuropsychiatric disorder characterized by increased daytime sleepiness, cataplexy and hypnagogic hallucinations. Deficiency of the hypocretin neurotransmitter system was shown to be involved in the pathogenesis of narcolepsy in animals and men. There are several hints that neurodegeneration of hypocretin producing neurons in the hypothalamus is the pathological correlate of narcolepsy. The <it>ApoE4</it> allele is a major contributing factor to early-onset neuronal degeneration in Alzheimer disease and other neurodegenerative diseases as well.</p> <p>Methods</p> <p>To clarify whether the ApoE4 phenotype predisposes to narcolepsy or associates with an earlier disease onset, we have genotyped the <it>ApoE</it> gene in 103 patients with narcolepsy and 101 healthy controls.</p> <p>Results</p> <p>The frequency of the E4 allele of the <it>ApoE</it> gene was 11% in the patient and 15% in the control groups. Furthermore, the mean age of onset did not differ between the ApoE4<sup>+</sup> and ApoE4<sup>-</sup> patient groups.</p> <p>Conclusion</p> <p>Our results exclude the <it>ApoE4</it> allele as a major risk factor for narcolepsy.</p> |
|---|---|
| Item Description: | 10.1186/1471-2350-2-9 1471-2350 |